Joined March 2015
- Tweets 30,095
- Following 2,205
- Followers 40,696
- Likes 34,059
4,313 Photos and videos
⭐️A milestone in #PrecisionMedicine 👉🏼Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM
@ASCO @NEJM
1
1
81
🚨⭐️Pleased to share the final version our new paper in @NaturePortfolio @Nature_NPJ @Nature NPJ Precision Oncology 👉🏼A unified framework for pre‑screening and screening in oncology trials.
👉🏼As eligibility grows more complex, hybrid digital AI‑enabled approaches can streamline matching, improve and accelerate access to investigational therapies. Grateful to collaborate with this stellar team. @DrArturoAI @euapmbrussels @united4cancer @OncoAlert @OpenMedicineHQ
nature.com/articles/s41698-0…
4
5
154
Enhancing biopharma research & development | McKinsey mckinsey.com/industries/life…
99
🏆🏆🏆🎉🎉🎉
FOR THE FIRST TIME IN 53 YEARS, THE KNICKS ARE NBA CHAMPIONS 🏆
New York defeats San Antonio 4-1 in the NBA Finals, capturing their third championship in franchise history!
4
699
Jun 13
🚨Tumor-Agnostic Therapies: Translating Scientific Breakthroughs Into Global Implementation | Journal of Clinical Oncology @JCO_ASCO @ASCO @JiaJennyLiu @JulianaRBeal @niamhjcoleman @OncoAlert
ascopubs.org/doi/10.1200/JCO…
10
21
1,507
Jun 13
Lonvoguran Ziclumeran — In Vivo CRISPR Gene Editing in Hereditary Angioedema | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
1
3
8
819
Jun 13
Talquetamab–Daratumumab in Relapsed or Refractory Myeloma | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
2
13
835
Jun 13
FDA Approves Capivasertib Plus Abiraterone and Prednisone for Metastatic Prostate Cancer - The ASCO Post ascopost.com/news/june-2026/…
2
1
16
1,065
Jun 13
🚨While @SpaceX goes IPO and the world's glued to @FIFAWorldCup ⚽🚀an interesting paper popped up for your Friday read @NatureMedicine
👉Frontier general LLMs (GPT-5.2, Gemini 3.1 Pro, Claude Opus 4.6) outperformed specialized clinical AI tools (OpenEvidence, UpToDate Expert AI) on medical knowledge, clinician alignment 1,800 blinded physician annotations on real clinical queries🤯
👉This result was unexpected 🤯🤔 👉"Specialized" ≠ "Better" @OncoAlert
nature.com/articles/s41591-0…
2
22
48
9,912
Jun 12
General-purpose large language models outperform specialized clinical AI tools on medical benchmarks | Nature Medicine nature.com/articles/s41591-0…
1
5
7
1,056
Vivek Subbiah, MD retweeted
Wow! Customized combination
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer | OncLive onclive.com/view/vopimetosta…
1
2
22
6,832
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer | OncLive onclive.com/view/vopimetosta…
1
20
57
9,319
Vivek Subbiah, MD retweeted
Now online in @CD_AACR: A Foundation Model of Cancer Genotype Enables Precise Predictions of Therapeutic Response - by JungHo Kong, @zhenwang9102, @TreyIdeker, and colleagues @UCSanDiego
May 27
Now online: A foundation model of cancer genotype enables precise predictions of therapeutic response doi.org/10.1158/2159-8290.CD…
10
26
6,085
Vivek Subbiah, MD retweeted
While @VivekSubbiah is on a stellar @ASCOPost board, the @ASCO Daily News team at #ASCO26 would like a word! Superstars @neerajaiims @aakonc @montypal @Dr_JeannyAC @drebonyhoskins @VamsiVelcheti @rachnatshroff @MeganKruseMD 😎
Might have to settle this on a softball field 😉🥎
⭐️Such a delight to attend the 2026 @ASCOPost Advisory Board meeting at @ASCO #ASCO26 in Chicago! 🙌
👉Fantastic discussion on what goes into ASCO Post & how to share the greatest updates in oncology. Incredible teamwork spearheaded by @jamecancerdoc , Cara Glynn, and the amazing team
📸 Photo credit: Matt Herp 🙏 #ConexiantAtASCO #ASCO @ConquerCancerFd @JCO_ASCO
7
22
2,935
Vivek Subbiah, MD retweeted
So many wonderful leaders in cancer care l📸
⭐️Such a delight to attend the 2026 @ASCOPost Advisory Board meeting at @ASCO #ASCO26 in Chicago! 🙌
👉Fantastic discussion on what goes into ASCO Post & how to share the greatest updates in oncology. Incredible teamwork spearheaded by @jamecancerdoc , Cara Glynn, and the amazing team
📸 Photo credit: Matt Herp 🙏 #ConexiantAtASCO #ASCO @ConquerCancerFd @JCO_ASCO
1
10
1,133
Vivek Subbiah, MD retweeted
Jun 8
Such A Delight To Attend The 2026 The ASCO Post Advisory Board Meeting - Vivek Subbiah (@VivekSubbiah)
oncodaily.com/voices/vivek-s…
2
6
412
⭐️Such a delight to attend the 2026 @ASCOPost Advisory Board meeting at @ASCO #ASCO26 in Chicago! 🙌
👉Fantastic discussion on what goes into ASCO Post & how to share the greatest updates in oncology. Incredible teamwork spearheaded by @jamecancerdoc , Cara Glynn, and the amazing team
📸 Photo credit: Matt Herp 🙏 #ConexiantAtASCO #ASCO @ConquerCancerFd @JCO_ASCO
3
6
37
6,453
👏🏼👏🏼👏🏼🏆
1
989